Madison C. Garibotti

Toronto, ON M3J1P3, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

2nd NMD4C basic research summer school on promoting standardized protocols to advance translational research in neuromuscular disorders.

2nd NMD4C basic research summer school on promoting standardized protocols to advance translational research in neuromuscular disorders.

Journal: Journal of neuromuscular diseases

Published: December 19, 2025

Mitochondrial-targeted plastoquinone therapy prevents early onset muscle weakness that occurs before atrophy during ovarian cancer.

Mitochondrial-targeted plastoquinone therapy prevents early onset muscle weakness that occurs before atrophy during ovarian cancer.

Journal: Molecular metabolism

Published: April 22, 2025

Adiponectin-receptor agonism prevents right ventricular tissue pathology in a mouse model of Duchenne muscular dystrophy.

Adiponectin-receptor agonism prevents right ventricular tissue pathology in a mouse model of Duchenne muscular dystrophy.

Journal: Molecular metabolism

Published: March 13, 2025

Mitochondrial-targeted plastoquinone therapy ameliorates early onset muscle weakness that precedes ovarian cancer cachexia in mice.

Mitochondrial-targeted plastoquinone therapy ameliorates early onset muscle weakness that precedes ovarian cancer cachexia in mice.

Journal: bioRxiv : the preprint server for biology

Published: November 01, 2024

The mitochondrial-targeted antioxidant SkQ1 prevents skeletal muscle mitochondrial-apoptotic but not necroptotic signalling during ovarian cancer.

The mitochondrial-targeted antioxidant SkQ1 prevents skeletal muscle mitochondrial-apoptotic but not necroptotic signalling during ovarian cancer.

Journal: The Journal of physiology

Published: October 31, 2024

Mitohormesis during advanced stages of Duchenne muscular dystrophy reveals a redox-sensitive creatine pathway that can be enhanced by the mitochondrial-targeting peptide SBT-20.

Mitohormesis during advanced stages of Duchenne muscular dystrophy reveals a redox-sensitive creatine pathway that can be enhanced by the mitochondrial-targeting peptide SBT-20.

Journal: Redox biology

Published: August 14, 2024

Muscle weakness and mitochondrial stress occur before metastasis in a novel mouse model of ovarian cancer cachexia.

Muscle weakness and mitochondrial stress occur before metastasis in a novel mouse model of ovarian cancer cachexia.

Journal: bioRxiv : the preprint server for biology

Published: April 22, 2024

Muscle weakness and mitochondrial stress occur before severe metastasis in a novel mouse model of ovarian cancer cachexia.

Muscle weakness and mitochondrial stress occur before severe metastasis in a novel mouse model of ovarian cancer cachexia.

Journal: Molecular metabolism

Published: April 11, 2024

The slow-release adiponectin analog ALY688-SR modifies early-stage disease development in the D2.mdx mouse model of Duchenne muscular dystrophy.

The slow-release adiponectin analog ALY688-SR modifies early-stage disease development in the D2.mdx mouse model of Duchenne muscular dystrophy.

Journal: American journal of physiology. Cell physiology

Published: December 25, 2023

Cardiac Atrophy, Dysfunction, and Metabolic Impairments: A Cancer-Induced Cardiomyopathy Phenotype.

Cardiac Atrophy, Dysfunction, and Metabolic Impairments: A Cancer-Induced Cardiomyopathy Phenotype.

Journal: The American journal of pathology

Published: November 28, 2023

Age-related changes of skeletal muscle metabolic response to contraction are also sex-dependent.

Age-related changes of skeletal muscle metabolic response to contraction are also sex-dependent.

Journal: The Journal of physiology

Published: October 19, 2023

Strength athletes and mitochondria: it's about 'time'.

Strength athletes and mitochondria: it's about 'time'.

Journal: The Journal of physiology

Published: May 30, 2023

Showing 1-12 of 14

Last Updated: 09/26/2026